Efficacy of S-1 after pemetrexed in patients with non-small cell lung cancer: A retrospective multi-institutional analysis.
Shinnosuke TakemotoKazumasa AkagiSawana OnoHiromi TomonoNoritaka HondaTakayuki SuyamaYasuhiro UmeyamaYosuke DotsuHirokazu TaniguchiDaiki OgawaraHiroaki SenjuHiroshi GyotokuNanae SugasakiHiroyuki YamaguchiKatsumi NakatomiMinoru FukudaHiroshi MukaePublished in: Thoracic cancer (2021)
Although there were several limitations in this study, the ORR of S-1 after PEM in patients with nonsquamous (non-SQ) NSCLC was low compared to the historical control. One of the options in the future might be to avoid S-1 treatment in PEM-treated patients who need tumor shrinkage.